Acute myeloid leukemia (AML) treatment is challenging in older patients...
VEN+AZA and VEN+LDAC demonstrated improved efficacy compared to alternative therapies among treatment naïve patients with AML ineligible for intensive chemotherapy.
Allogeneic hematopoietic stem cell transplantation (HSCT) is highly effective for treating pediatric high-risk or relapsed acute lymphoblastic leukemia (ALL)...
No abstract text is available for this article
The CFA ratio, calculated using pretreatment C-reactive protein (CRP), fibrinogen, and albumin levels (CRP × fibrinogen/albumin), was previously reported to be a significant prognostic factor for acute myeloid leukemia (AML)...
Venetoclax (VEN) combination regimens are now recognized as effective against acute myeloid leukemia (AML)...
Vincristine (VCR) is a vital component in numerous treatment regimens for pediatric blood cancer...